Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Inari Medical by Year
Inari Medical (Standalone Pre-Acquisition through FY2024Q3) — Gross Margin (%) (%)
Stryker Inari Medical: 88.0% in FY2023, down 0.4 pts from a year earlier. No newer figure appears in the documents we track.
Latest, FY2023
88.0%
Period ended Dec 31, 2023
Change on a year earlier
-0.4 pts
88.4% in FY2022
History
5 years
Since FY2019
Sources
4
Documents cited below
Where the FY2023 figure comes from
“Gross margin for the year ended December 31, 2023 decreased to 88.0%, compared to 88.4% for the year ended December 31, 2022.”
Reported in Inari Medical, Inc. (NARI) Form 10-K, Form 10-Q & Form 8-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inari Medical (Standalone Pre-Acquisition through FY2024Q3) — Gross Margin (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 88.0% | -0.4 pts | Inari Medical Form 10-K (0001531048-24-000024|nari-20231231.htm) ↗ |
| FY2022 | Dec 31, 2022 | 88.4% | -2.7 pts | Inari Medical Form 10-K (0001531048-24-000024|nari-20231231.htm) ↗ |
| FY2021 | Dec 31, 2021 | 91.1% | +0.5 pts | Inari Medical Form 10-K (0000950170-23-004675|nari-20221231.htm) ↗ |
| FY2020 | Dec 31, 2020 | 90.6% | +2.2 pts | Inari Medical Form 10-K (0000950170-22-001783|nari-20211231.htm) ↗ |
| FY2019 | Dec 31, 2019 | 88.4% | – | Inari Medical Form 10-K (0001564590-21-011763|nari-10k_20201231.htm) ↗ |
Breakdown
What makes up inari Medical
- Inari Medical (Standalone through FY2024Q3) — Gross Profit ($M)435 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Cost of Goods Sold ($M)59.1 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Research & Development Expense ($M)87.5 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Selling, General & Administrative Expense ($M)361 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Operating Income / (Loss) ($M)-14.0 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Net Income / (Loss) ($M)-1.64 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Operating Cash Flow ($M)35.9 · FY2023
- Inari Medical (Standalone through FY2024Q3) — Capital Expenditures ($M)4.71 · FY2023
Cite this data
StockData. (2026). Stryker Inari Medical (%), annual FY2019–FY2023 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-gm-pct
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.